Leoni A Kunz-Schughart Selected Research

Drug Therapy (Chemotherapy)

1/2009	Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma.
7/2008	Temozolomide preferentially depletes cancer stem cells in glioblastoma.
3/2007	Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leoni A Kunz-Schughart Research Topics

Disease

56	Neoplasms (Cancer) 04/2024 - 11/2002
10	Carcinoma (Carcinomatosis) 12/2021 - 06/2003
9	Colorectal Neoplasms (Colorectal Cancer) 03/2021 - 09/2009
6	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2006
5	Starvation 01/2021 - 05/2012
4	Squamous Cell Carcinoma of Head and Neck 03/2022 - 01/2016
4	Neoplasm Metastasis (Metastasis) 08/2011 - 06/2003
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2015
3	Glioma (Gliomas) 12/2019 - 12/2004
3	Hypoxia (Hypoxemia) 01/2016 - 02/2011
3	Tics (Tic) 01/2016 - 09/2009
3	Melanoma (Melanoma, Malignant) 01/2009 - 12/2004
2	Hyperthermia 06/2021 - 01/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016 - 08/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2014 - 01/2013
1	Neutropenia 04/2024
1	T-Cell Leukemia (Leukemia, T Cell) 12/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Metabolic Diseases (Metabolic Disease) 01/2017
1	Cholera 09/2010
1	Whooping Cough (Pertussis) 09/2010

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2003
9	Arginine (L-Arginine)FDA Link 03/2021 - 05/2012
7	Lactic Acid (Lactate)FDA LinkGeneric 08/2011 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2004
5	Amino Acids FDA Link 01/2021 - 05/2012
3	Messenger RNA (mRNA)IBA 03/2022 - 11/2002
2	ProdrugsIBA 04/2024 - 12/2021
2	Antineoplastic Agents (Antineoplastics)IBA 04/2024 - 10/2007
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2019
2	CanavanineIBA 03/2021 - 05/2012
2	ArginaseIBA 03/2021 - 05/2012
2	Aldehyde DehydrogenaseIBA 01/2021 - 04/2015
2	SuspensionsIBA 01/2020 - 10/2002
2	Methionine (L-Methionine)FDA Link 01/2017 - 11/2013
2	CitrullineIBA 11/2016 - 11/2013
2	AntibodiesIBA 01/2016 - 03/2006
2	ErbB Receptors (EGF Receptor)IBA 08/2014 - 01/2013
2	Cetuximab (Erbitux)FDA Link 08/2014 - 01/2013
2	EnzymesIBA 05/2012 - 02/2011
2	CytokinesIBA 08/2011 - 03/2006
2	Calcibiotic Root Canal SealerIBA 03/2010 - 09/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2009 - 08/2005
2	PPAR gammaIBA 01/2009 - 03/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2007 - 03/2006
2	Conditioned Culture MediaIBA 03/2006 - 05/2003
2	Interleukin-6 (Interleukin 6)IBA 03/2006 - 05/2003
1	CamptothecinIBA 04/2024
1	EstersIBA 04/2024
1	Oxygen (Dioxygen)IBA 11/2023
1	Chimeric Antigen ReceptorsIBA 03/2022
1	Heavy Chain Fusion Regulatory Protein 1IBA 03/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	p21-Activated KinasesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021
1	TOR Serine-Threonine KinasesIBA 03/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2021
1	indospicineIBA 03/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Tricarboxylic AcidsIBA 12/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2019
1	NADP (NADPH)IBA 12/2019
1	Essential Amino AcidsIBA 01/2017
1	AsparagineIBA 01/2017
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 11/2016
1	Tumor Suppressor Protein p53IBA 02/2016
1	Integrin beta1IBA 01/2016
1	Antimalarials (Antimalarial Agents)IBA 01/2016
1	UbiquinoneIBA 01/2016
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2016
1	IntegrinsIBA 01/2016
1	Atovaquone (Mepron)FDA Link 01/2016
1	CateninsIBA 04/2015
1	Radioisotopes (Radionuclides)IBA 08/2014
1	Lysine (L-Lysine)FDA Link 11/2013
1	Leucine (L-Leucine)FDA Link 11/2013
1	Polo-Like Kinase 1IBA 09/2013
1	BI 6727IBA 09/2013
1	EpitopesIBA 02/2013
1	AC133 AntigenIBA 02/2013
1	A-factor (Streptomyces)IBA 05/2012
1	Pyruvic Acid (Pyruvate)IBA 08/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2011
1	baysilon (polydimethylsiloxane)IBA 02/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011
1	Pioglitazone (Actos)FDA Link 01/2011
1	PPAR-gamma AgonistsIBA 01/2011
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2011

Therapy/Procedure

22	Therapeutics 11/2023 - 11/2002
11	Radiotherapy 11/2023 - 04/2012
3	Drug Therapy (Chemotherapy) 01/2009 - 03/2007
2	Chemoradiotherapy 03/2022 - 01/2019
1	Immunotherapy 03/2022
1	Proton Therapy 08/2021
1	Induced Hyperthermia (Thermotherapy) 06/2021
1	Precision Medicine 01/2020
1	Aftercare (After-Treatment) 01/2016
1	Lasers (Laser) 04/2011